ANVISA: 90% CI for AUCINF in 72hrs truncated BE Study [Regulatives / Guidelines]

posted by Nirali – India, 2007-09-21 08:26 (6857 d 10:12 ago) – Posting: # 1104
Views: 8,068

Dear Group Members,

Is calculation of 90%CI required for AUCINF while doing ANVISA submission for 72hrs truncated single dose, crossover BE study?

Product has long half life-70hrs. Therefore planned to truncate AUC upto 72hrs. ANVISA guideline has not clearly mentioned that 90%CI for AUCINF is required or not, for the same.

Would you pls explain the importance of AUCINF in 72hrs-truncated BE study?


Thanks & Regards,
Nirali

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
309 visitors (0 registered, 309 guests [including 23 identified bots]).
Forum time: 18:38 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5